Buy Atara's T-Cell Potential, Stock Could Nearly Double: Canaccord
September 09, 2015 at 09:04 AM EDT
The share price of Atara Biotherapeutics, Inc. (NASDAQ: ATRA) has risen almost 8 percent over the past trading five ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.